Laryngotracheobronchitis: 2 years' experience with racemic epinephrine.
A relatively new form of treatment of laryngotracheobronchitis, administration of racemic epinephrine by intermittent positive-pressure breathing, was begun in 1973 in the pediatric unit of a large community hospital. A review of 2 years' experience with this treatment, compared with the experience of the 3 years prior to its introduction, has shown that it has reduced significantly the necessity for tracheostomy, to nearly zero, and the duration of hospital stay. A total of 119 children (33.15% of those admitted) received this treatment, the average number of treatments required being 1.8. There were no important complications of treatment and no deaths.
D000293:Adolescent; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007384:Intermittent Positive-Pressure Breathing; D007827:Laryngitis / Q000188:drug therapy*; D007902:Length of Stay; D008297:Male; D064705:Racepinephrine; D014136:Tracheitis / Q000188:drug therapy*; D014140:Tracheotomy
D064705:Racepinephrine; D004837:Epinephrine